stock
CYPH · CYPHERPUNK TECHNOLOGIES INC.
What CYPHERPUNK TECHNOLOGIES INC. reports to the SEC, read from its filings.
Open in the appPrice
The live CYPH price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on CYPH.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 107,764,382 as of 2026-08-10 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -0.5%
- ROA
- -0.5%
Health
- Current ratio
- 79.2x
- Debt/equity
- —
Deep value
- NCAV
- $133.90M
- NCAV per share
- $1.24
- Price/NCAV
- Locked
- NNWC
- $3.97M
- NNWC per share
- $0.04
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | — | —Gross profit: unreported by this company. | -$4.69M | $39.39M | 10-Q filed 2026-08-12 |
| 2026-03-31 | — | —Gross profit: unreported by this company. | -$4.82M | -$77.17M | 10-Q filed 2026-05-14 |
| 2025-12-31 | — | —Gross profit: unreported by this company. | -$5.10M | $40.38M | DEF 14A filed 2026-04-29 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | — | —Gross profit: unreported by this company. | -$3.17M | -$3.30M | 10-Q filed 2025-11-12 |
| 2025-06-30 | — | —Gross profit: unreported by this company. | -$16.88M | -$16.64M | 10-Q filed 2026-08-12 |
| 2025-03-31 | — | —Gross profit: unreported by this company. | -$15.92M | -$15.44M | 10-Q filed 2026-05-14 |
| 2024-12-31 | — | —Gross profit: unreported by this company. | -$16.13M | -$15.88M | DEF 14A filed 2026-04-29 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | — | —Gross profit: unreported by this company. | -$17.86M | -$18.18M | 10-Q filed 2025-11-12 |
- Assets
- $142.97M
- Equity
- $139.32M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$41.07M | $5.00M | — |
| 2024-12-31 | — | -$70.06M | -$68.00M | — |
| 2023-12-31 | — | -$87.04M | -$81.00M | — |
| 2022-12-31 | — | -$56.76M | -$54.60M | — |
| 2021-12-31 | $1.50M | -$41.43M | -$40.59M | — |
| 2020-12-31 | $1.50M | -$28.54M | -$27.51M | — |
| 2019-12-31 | — | -$33.45M | -$32.90M | -$27.00M |
| 2018-12-31 | — | -$30.75M | -$23.14M | — |
| 2017-12-31 | — | -$32.35M | -$29.73M | -$22.20M |
| 2016-12-31 | — | -$27.30M | -$25.63M | -$25.48M |
Company filings
1 offering filing in 12 months · since Wed Nov 12
events
Executive or director change, Regulation FD disclosure
Executive or director changeRegulation FD disclosureSep 228-KOther event
Other eventSep 28-KMaterial agreement, Unregistered share sale, Other event
Material agreementUnregistered share saleOther eventAug 188-KResults, Other event
ResultsOther eventAug 128-KListing standard notice
Listing standard noticeJul 218-KShareholder vote results
Shareholder vote resultsJun 228-K
5% owners ()
Winklevoss Capital Fund, LLC
Stake update
GILEAD SCIENCES, INC.
Stake update
Winklevoss Capital Fund, LLC
Stake update
Severns Sean Michael
Passive stake
Winklevoss Capital Fund, LLC
Activist stake
Insiders, politicians and funds
Insider trades, last 90 days
Oei Khing Djien
Director
Sale$661,500Sep 25, 6:14 PM ET
Martin Patricia A.
Director
Sale$193,000Sep 25, 6:13 PM ET
Dietz Thomas John
Director
Sale$34,400Aug 27, 4:30 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named CYPH, and the market events around them.
Sign in to see thisBoard
The CYPH board could not be loaded.
Retry the CYPH boardnakagai
Signals on CYPH come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the CYPH board